Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.07
+0.43 (0.90%)
At close: Jun 26, 2026, 4:00 PM EDT
48.01
-0.06 (-0.12%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Novo Nordisk Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Mar 31, 2026 | 197.00B | 84.84B | 19.20B |
| Dec 31, 2025 | 207.11B | 82.35B | 19.61B |
| Sep 30, 2025 | 214.33B | 81.31B | 19.96B |
| Jun 30, 2025 | 213.12B | 79.00B | 19.82B |
| Mar 31, 2025 | 211.73B | 72.54B | 18.87B |
| Dec 31, 2024 | 206.62B | 65.15B | 18.64B |
| Sep 30, 2024 | 198.11B | 54.97B | 17.51B |
| Jun 30, 2024 | 192.75B | 48.42B | 16.83B |
| Mar 31, 2024 | 182.45B | 44.83B | 16.97B |
| Dec 31, 2023 | 173.47B | 41.63B | 17.16B |
| Sep 30, 2023 | 161.15B | 35.89B | 17.45B |
| Jun 30, 2023 | 154.71B | 27.97B | 18.65B |
| Mar 31, 2023 | 147.23B | 21.30B | 19.76B |
| Dec 31, 2022 | 139.55B | 16.86B | 20.54B |
| Sep 30, 2022 | 132.96B | 13.84B | 20.40B |
| Jun 30, 2022 | 125.55B | 11.90B | 19.80B |
| Mar 31, 2022 | 119.19B | 10.25B | 19.59B |
| Dec 31, 2021 | 113.20B | 8.40B | 19.20B |
| Sep 30, 2021 | 105.64B | 7.15B | 18.96B |
| Jun 30, 2021 | 100.70B | 6.22B | 19.26B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.